target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics

It prevents overinterpretation of noise as biology.

October 2022 "Enzymatic and cellular signalling biosensors are used to decipher the activities of complex biological

Every ligand you design enters a system that is already balancing opposing forces—vasoconstriction vs toward the clinic, this is a blueprint for building a more reliable evidence base—one that accounts for biology

Moreover, the study's insights into the structural and functional consequences of specific phosphorylation

Crystal structures suggest ligand access to the orthosteric binding site of MT1 and MT2 receptors through

; Endocrine Metabolic GPCRs 2026 and Biophysical Society Meeting previews; positive ACCESS data for Structure

HLGR2 is a typical GPCR and shows high structural and sequence similarity with other insect LGR2 proteins

Barry Rubenstein as Senior Vice President, People and Culture and Washington Alves as Vice President, Biologics

Often, a low EC50 indicates high potency, but this isn't always the case due to various biological factors

August 2022 "Chemokines, a subgroup of cytokines along with their receptors, are involved in various biologic

Enter ANOVA (Analysis of Variance).   right replicate count to balance rigor and efficiency Choose the correct statistical test for your data structure

Biology of the Cell, 93(1‐2), 71-79. Wei, H., Ahn, S., Shenoy, S. K., Karnik, S.

and the multifunctional scaffolding protein β-arrestin2 are key integrated signaling nodes in various biological

extensively studied GPCR that can provide insight into this aspect of GPCR signaling thanks to robust structural

It is also one of the most structurally demanding targets a discovery team can take on, because the amylin

manner, and triggered the formation of cell condensations that developed aligned, anisotropic neotissue structures

Hilger, D., et al., Structural insights into differences in G protein activation by family A and family

Screening technologies, structure-informed design, and AI are accelerating target selection. Antibodies, Bias, and the Expanding Modality Landscape Antibody therapeutics are now entering spaces

Understanding activation dynamics gives discovery teams a new design frontier: instead of blocking biology

technologies that stabilize G protein–coupled receptors (GPCRs) to enable the discovery of agonistic biologics

Salahpour, A., et al., BRET biosensors to study GPCR biology, pharmacology, and signal transduction. 

The involvement of chemokines and their receptors in several aspects of cancer biology, represents a

If you stop at potency, structure–activity relationships (SARs) may look flat.

particular show a progressive tendency to aggregate and precipitate in aqueous solution outside of their biological

enrichment analysis indicated that the mechanism of KXS in treating depression was involved in the biological

Expression is directed by the endogenous mouse promoter and hence occurs in all biologically relevant

Antibody developers are increasingly utilising antibody libraries to derive high-quality, drug-like biologics

You can consult the article at the following link: https://www.ecosystem.drgpcr.com/structural-and-molecular-insights-into-gpcr-function Struct. Mol. Biol. 15:658–664.

Two compounds can show identical affinities on paper, but their biological outcomes can differ dramatically